Project Title: A novel therapeutic target in pancreatic cancer: Implications for therapy and diagnosis

curtin falasca 300x450

Institution: Curtin University

Principal Investigator: Dr Marco Falasca

Position Held: Professor

Time required to complete project: 3 years

Project Summary: The project team have discovered that a protein named GPR55 promotes pancreatic cancer growth. Their preliminary data demonstrates that a GPR55 inhibitor, in combination with a drug used in therapy, is able to increase survival in mice that develop pancreatic cancer. The project team’s plan is to identify more potent drug combinations to treat pancreatic cancer and also identify new marker that will enable to diagnose pancreatic cancer earlier.

View Media Release